These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 957503)

  • 1. Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers.
    Drach GW
    J Urol; 1976 Sep; 116(3):338-40. PubMed ID: 957503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of some biochemical parameters in pyridoxine-treated calcium oxalate renal stone formers.
    Revúsová V; Gratzlová J; Zvara V; Kridl J; Suchánek B; Breza J
    Urol Int; 1977; 32(4):348-52. PubMed ID: 929778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative element investigations in urine, serum, kidney and muscle tissue of calcium oxalate stone patients.
    Matouschek E; Huber R; Schneider J; Vogg H
    Eur Urol; 1978; 4(3):206-11. PubMed ID: 658076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and glucose load studies in uric acid, oxalic and hyperparathyroid stone formers.
    Schwille PO; Scholz D; Hagemann G; Sigel A
    Adv Exp Med Biol; 1974; 41():485-94. PubMed ID: 4832572
    [No Abstract]   [Full Text] [Related]  

  • 7. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.
    Schwille PO; Scholz D; Schwille K; Leutschaft R; Goldberg I; Sigel A
    Nephron; 1982; 31(3):194-202. PubMed ID: 7121665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of uric acid in calcium oxalate nephrolithiasis].
    Hartung R
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):387-90. PubMed ID: 804601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of bendroflumethiazide in patients with recurrent calcium oxalate stone disease.
    Ahlstrand C; Tiselius HG
    J Urol; 1981 Nov; 126(5):635-9. PubMed ID: 7299925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic study of hyperparathyroid and other renal stone formers using a very low intake of calcium and magnesium.
    Keynes WM; Barnes BA; Gordon E; Cope O
    Br J Surg; 1969 Aug; 56(8):624. PubMed ID: 5797755
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers.
    Coe FL; Moran E; Kavalich AG
    J Chronic Dis; 1976 Dec; 29(12):793-800. PubMed ID: 1010873
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat.
    Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M
    Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1537-41. PubMed ID: 3213789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of nutritional status, laboratory parameters and dietary patterns upon urinary acid excretion in calcium stone formers.
    Tessaro CZW; Ramos CI; Heilberg IP
    J Bras Nefrol; 2018; 40(1):35-43. PubMed ID: 29796583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.